Benzylguanidines and Other Galegine Analogues
Journal of Medicinal Chemistry, 2009, Vol. 52, No. 11 3463
(24) Vaillancourt, V. A.; Larsen, S. D.; Tanis, S. P.; Burr, J. E.; Connell,
M. A.; Cudahy, M. M.; Evans, B. R.; May, P. D.; Meglasson, M. D.;
Robinson, D. D.; Stevens, F. C.; Tucker, J. A.; Vidmar, T. J.; Yu,
J. H. Synthesis and biological activity of aminoguanidine and
diaminoguanidine analogues of the antidiabetic/antiobesity agent
3-guanidinopropionic acid. J. Med. Chem. 2001, 44, 1231–1248.
(25) Larsen, S. D.; Tanis, S. P.; Burr, J. E.; Connell, M. A.; Cudahy, M. M.;
Evans, B. R.; May, P. D.; Meglasson, M. D.; Robinson, D. D.; Stevens,
F. C.; Tucker, J. A.; Vaillancourt, V. A.; Vidmar, T. J.; Yu, J. H.
Synthesis and biological activity of aminoguanidine and diaminoguani-
dine analogues of the antidiabetic/antiobesity agent 3-guanidinopro-
pionic acid. J. Med. Chem. 2001, 44, 1217–1230.
(26) Tassoni, E.; Giannessi, E.; Brunetti, T.; Pessotto, P.; Renzulli, M.;
Travagli, M.; Rajama¨ki, S.; Prati, S.; Dottori, S.; Corelli, F.; Cabri,
W.; Carminati, P.; Botta, M. Novel substituted alkylaminoguanidines
as potential antihyperglycemic and food intake reducing agents. J. Med.
Chem. 2008, 51, 3073–3076.
(27) Roginsky, M. S.; Sandler, J. Phenformin in human obesity. Ann. N.Y.
Acad. Sci. 1968, 148, 892–896.
(28) McManus, J. M. Process for lowering blood sugar levels. U.S. Patent
Appl. 132,803, 1971.
(29) Shah, R. R.; Evans, D. A.; Oates, N. S.; Idle, J. R.; Smith, R. L. The
genetic control of phenformin 4-hydroxylation. J. Med. Genet. 1985,
22, 361–366.
(30) Bosisio, E.; Kienle, M. G.; Galli, G.; Ciconali, M.; Negri, A.; Sessa,
A.; Morosati, S.; Sirtori, C. R. Defective hydroxylation of phenformin
as a determinant of drug toxicity. Diabetes 1981, 30, 644–649.
(31) Fujita, H.; Fujishima, H.; Koshimura, J.; Hosoba, M.; Yoshioka, N.;
Shimotomai, T.; Morii, T.; Narita, T.; Kakei, M.; Ito, S. Effects of
antidiabetic treatment with metformin and insulin on serum and adipose
tissue adiponectin levels in db/db mice. Endocr. J. 2005, 52, 427–
433.
(32) Desvages, G.; Olomucki, M. Research on the derivatives of guanidines
from Galega officinalis. L: galegine and hydroxygalegine. Bull. Soc.
Chim. Fr. 1969, 3229-3232.
(33) Prasad, R. N.; McKay, A. F. Acylation of guanidines and guanylhy-
drazaones. Can. J. Chem. 1967, 45, 2247–2252.
(34) Braun, C. E.; Randall, W. M. The preparation of some monoguanidines
of possible physiological significance. J. Am. Chem. Soc. 1934, 56,
2134–2137.
(35) Nishimura, T.; Toku, H.; Kono, T.; Sakabe, Y.; Sakaguchi, T. Studies
on the Voges-Proskauer reaction. I. Structure of positive substances
in the diacetyl reaction. Chem. Pharm. Bull. 1969, 17, 639–649.
(36) Bream, J. B.; Lauener, H.; Picard, C. W.; Scholtysik, G.; White, T. G.
Substituted phenylacetylguanidines: a new class of antihypertensive
agents. Arzneim.-Forsch. 1975, 25 (10), 1477–1482.
(37) Ovsepyan, T. R.; Akopyan, P. R.; Safrazbekyan, R. R.; Sukasyan,
R. S.; Arzanunts, E. M.; Sarkisyan, I. S.; Engoyan, A. P.; Karapetyan,
A. A.; Struchkov, Yu. T. Synthesis and antimonoamineoxidase activity
of 4-methoxybenzylguanidine and its sulfate. Pharm. Chem. J. 1998,
12, 641–643.
(38) Villarroya, M.; Gand´ıa, L.; Lo´pez, M. G.; Garc´ıa, A. G.; Cueto, S.;
Jose´-Luis Garc´ıa-Navio, J.-L.; Alvarez-Builla, J. Synthesis and
pharmacology of alkanediguanidinium compounds that block the
neuronal nicotinic acetylcholine receptor. Bioorg. Med. Chem. 1996,
4, 1177–1184.
details listed for all compounds prepared. This material is available
References
(1) Bailey, C. J.; Day, C. Metformin: its botanical background. Pract.
Diabetes Int. 2004, 21, 115–117.
(2) Witters, L. A. The blooming of the French lilac. J. Clin. InVest. 2001,
108, 1105–1107.
(3) Ungar, G.; Freedman, L.; Shapiro, S. L. Pharmacological studies of a
new oral hypoglycemic drug. Proc. Soc. Exp. Biol. Med. 1957, 95,
190–192.
(4) Shapiro, S. L.; Parrino, V. A.; Freedman, L. Hypoglycemic agents.
III. N-Alkyl and aralkylbiguanides. J. Am. Chem. Soc. 1959, 81, 3728–
3736.
(5) Shapiro, S. L.; Parrino, V. A.; Freedman, L. Hypoglycemic agents. I.
Chemical properties of ꢀ-phenethylbiguanide. A new hypoglycemic
agent. J. Am. Chem. Soc. 1959, 81, 2220–2225.
(6) Hesse, E.; Taubmann, G. Die wirkung des biguanids und seiner derivate
auf den zuckerstoffwechsel. Naunyn-Schmiedeberg’s Arch. Pharmacol.
1929, 291-308.
(7) Kolata, G. B. The phenformin ban: is the drug an imminent hazard?
Science 1979, 203, 1094–1096.
(8) Bailey, C. J.; Turner, R. C. Metformin. New Engl. J. Med. 1996, 334,
574–579.
(9) Palit, P.; Furman, B. L.; Gray, A. I. Novel weight-reducing activity of
Galega officinalis in mice. J. Pharm. Pharmacol. 1999, 51, 1313–1319.
(10) The Upjohn Company. A method for treatment of metabolic disorders.
International Pat. Appl. PCT/US92/06536, 1992.
(11) Vesell, E. S.; Beyer, K. H. Studies on pyrazinoylguanidine: a novel
antihypertensive, hypoglycemic and lipolytic drug intended for adjunc-
tive use in hypertensive patients with type 2 diabetes mellitus.
Toxicology 2000, 144, 1–3.
(12) Mooney, M. H.; Forgarty, S.; Stevenson, C.; Gallagher, A. M.; Palit,
P.; Hawley, S. A.; Hardie, D.; Coxon, G. D.; Waigh, R. D.; Tate,
R. J.; Harvey, A. L.; Furman, B. L. Mechanisms underlying the
metabolic actions of galegine that contribute to weight loss in mice.
Br. J. Pharmacol. 2008, 153, 1669–1677.
(13) Harwood, H. J.; Petras, S. F.; Shelly, L. D.; Zaccaro, L. M.; Perry,
D. A.; Makowski, M. R.; Hargrove, D. M.; Martin, K. A.; Tracey,
M. W. R.; Chapman, J. G.; Magee, W. P.; Dalvie, D. K.; Soliman,
V. F.; Martin, W. H.; Mularski, C. J.; Eisenbeis, S. A. Isoenzyme-
nonselective N-substituted bipiperidylcarboxamide acetyl-CoA car-
boxylase inhibitors reduce tissue malonyl-CoA concentrations, inhiBit
fatty acid synthesis, and increase fatty acid oxidation in cultured cells
and in experimental animals. J. Biol. Chem. 2003, 278, 37099–37111.
(14) Short, J. H.; Darby, T. D. Sympathetic nervous system blocking agents.
III. Derivatives of benzylguanidine. J. Med. Chem. 1967, 10, 833–
840.
(15) Houseknecht, K. L.; Baile, C. A.; Metteri, R. L.; Spurlock, M. E. The
biology of leptin. J. Anim Sci. 1998, 76, 1405–1420.
(16) Ren, J. Leptin and hyperleptinemiasfrom friend to foe for cardio-
vascular disease. J. Endocrinol. 2004, 181, 1–10.
(17) Perusse, L.; Bouchard, C. Gene-diet interactions in obesity. Am. J.
Clin. Nutr. 2000, 72 (5 Suppl), 1285S–1290S.
(18) Wilson, C. O.; Gisvold, O.; Doerge, R. F. Textbook of Organic
Medicinal and Pharmaceutical Chemistry, 7th ed.; J.B. Lippincott Co.:
Philadelphia, 1977; p 974.
(39) Boschetti, E.; Grand, M.; Molho, D.; Fontaine, L. Synthesis and
pharmacologic selection of new antihypertensive agents. Therapie
1968, 5, 1221–1232.
(40) Maggs, J. L.; Williams, D.; Pirmohamed, M.; Park, B. K. The
metabolic formation of reactive intermediates from clozapine, a drug
associated with agranulocytosis in man. Pharmacol. Exp. Ther. 1995,
275, 1463–1475.
(41) Lowry, O. H.; Rosbrough, N. J.; Farr, A. L.; Randall, R. J. Protein
measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193,
265–275.
(42) Watts, P.; Smith, M. D.; Edwards, I.; Zammit, V.; Brown, V.; Grant,
H. The influence of medium composition on the maintenance of
cytochrome P-450, glutathione content and urea synthesis: a com-
parison of rat and sheep primary hepatocyte cultures. J. Hepatol. 1995,
23, 605–612.
(19) Deves, R.; Boyd, C. A. R. Transporters for cationic amino acids in
animal cells: discovery, structure and function. Physiol. ReV. 1998,
78, 487–545.
(20) Wright, L. R.; Rothbard, J. B.; Wender, P. A. Guanidinium rich peptide
transporters and drug delivery. Curr. Protein Peptide Sci. 2003, 4,
105–124.
(21) Durant, G. J.; Emmett, J. C.; Ganellin, C. R.; Miles, P. D.; Parsons,
M. E.; Prain, H. D.; White, G. R. Cyanoguanidine-thiourea equivalence
in the development of the histamine H2-receptor antagonist, cimetidine.
J. Med. Chem. 1977, 20, 901–906.
(22) Koppel, I.; Koppel, J.; Leito, I.; Grehn, L. Basicity of 3-aminopro-
pionamidine derivatives in water and dimethyl sulphoxide. Implication
for a pivotal step in the synthesis of distamycin A analogues. J. Phys.
Org. Chem. 1998, 9, 265–268.
(43) Llambias, E. B.; Luo, J. Study of phenformin metabolism in rat liver
microsomes by HPLC, CE and on-line HPLC-electrospray ionization
mass spectrometry. Biomed. Chromatogr. 1996, 10, 155–60.
(23) Machado, H. J. S.; Hinchcliffe, A. Relationships between the HOMO
energies and pKa values in monocyclic and bicyclic azines. J. Mol.
Struct. (THEOCHEM) 1995, 339, 255–258.
JM8011933